|
Volumn 10, Issue 3, 2000, Pages 156-161
|
When to switch and what to switch to: Strategic use of antiretroviral therapy
|
Author keywords
Cycling protease inhibitors; Dual protease inhibitor regimens; Fusion inhibitors; Megaregimens; Salvage therapy
|
Indexed keywords
ADEFOVIR;
ANTIRETROVIRUS AGENT;
DELAVIRDINE;
EFAVIRENZ;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
CLINICAL PRACTICE;
CONFERENCE PAPER;
DRUG MECHANISM;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
SALVAGE THERAPY;
TREATMENT INDICATION;
TREATMENT PLANNING;
VIRUS LOAD;
ANTI-HIV AGENTS;
CARBAMATES;
CD4 LYMPHOCYTE COUNT;
DIDEOXYNUCLEOSIDES;
DRUG THERAPY, COMBINATION;
HIV PROTEASE INHIBITORS;
HUMANS;
INDINAVIR;
MICROBIAL SENSITIVITY TESTS;
MUTATION;
NELFINAVIR;
PRACTICE GUIDELINES;
PYRIMIDINONES;
RETROVIRIDAE;
RETROVIRIDAE INFECTIONS;
REVERSE TRANSCRIPTASE INHIBITORS;
SULFONAMIDES;
TIME FACTORS;
TREATMENT FAILURE;
VIRAL LOAD;
|
EID: 0034073473
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (5)
|
References (18)
|